Correlation Between Esperion Therapeutics and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and XORTX Therapeutics, you can compare the effects of market volatilities on Esperion Therapeutics and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and XORTX Therapeutics.
Diversification Opportunities for Esperion Therapeutics and XORTX Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Esperion and XORTX is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and XORTX Therapeutics
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.11 times more return on investment than XORTX Therapeutics. However, Esperion Therapeutics is 1.11 times more volatile than XORTX Therapeutics. It trades about 0.18 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 213.00 in Esperion Therapeutics on August 31, 2024 and sell it today you would earn a total of 41.00 from holding Esperion Therapeutics or generate 19.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. XORTX Therapeutics
Performance |
| Timeline |
| Esperion Therapeutics |
| XORTX Therapeutics |
Esperion Therapeutics and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and XORTX Therapeutics
The main advantage of trading using opposite Esperion Therapeutics and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| Esperion Therapeutics vs. Bausch Health Companies | Esperion Therapeutics vs. Haleon plc | Esperion Therapeutics vs. Intracellular Th |
| XORTX Therapeutics vs. Cue Biopharma | XORTX Therapeutics vs. Eliem Therapeutics | XORTX Therapeutics vs. Inhibrx | XORTX Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |